Period: 2025 – 2028

Researchers

Dr. Mabel Berrueta

Dr. Agustín Ciapponi

Dr. Agustina Mazzoni

Dr. Ariel Bardach

Dr. Jamile Ballivian

Lic. Rocío Rodriguez

Ana Paula Pérez Oyola, Esq.

Noelia Castellana, Esq.

Lic. Franco Scarafia

MSc. Álvaro Ciganda

Objective

Living Systematic Review (LSR) with meta-analysis on the effectiveness and immunogenicity of Pfizer's maternal RSVpreF vaccine (ABRYSVO) for preventing RSV-associated disease in infants.

Type of study

Live systematic review and meta-analysis

Finance

Pfizer